Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $75.1K invested in Intelligent Bio Solutions in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
91% less capital invested
Capital invested by funds: $799K → $75.1K (-$724K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.4K |
| 2 |
Jane Street
New York
|
+$4.79K |
| 3 |
SG
StoneX Group
New York
|
+$4.79K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gotham Asset Management
New York
|
-$661K |
| 2 |
VF
Virtu Financial
New York
|
-$5K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4K |
| 4 |
Renaissance Technologies
New York
|
-$959 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $23K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $21K | -$959 | -1 | -2% |
|
|
3
Citadel Advisors
Miami,
Florida
| $13.9K | +$14.4K | +15 | +107% |
|
4
State Street
Boston,
Massachusetts
| $6.82K | – | – | – |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $3.38K | – | – | – |
|
|
SG
6
StoneX Group
New York
| $2.63K | +$4.79K | +5 | New |
|
|
7
Jane Street
New York
| $2.24K | +$4.79K | +5 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $2.15K | +$3.84K | +4 | New |
|
9
Wells Fargo
San Francisco,
California
| $19 | – | – | – |
|
|
VF
10
Virtu Financial
New York
| – | -$5K | -5 | Closed |
|
|
11
Fidelity Investments
Boston,
Massachusetts
| – | -$4K | -4 | Closed |
|
|
GAM
12
Gotham Asset Management
New York
| – | -$661K | -4 | Closed |
|
INBS Hedge Fund Activity: Q4 2022 in Review
8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2022, worth a combined $75.1K — down 91% from $799K a quarter earlier.
Fund positioning in INBS was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $14.4K. The largest seller was Gotham Asset Management, exiting entirely with an estimated $661K sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $75.1K of Intelligent Bio Solutions stock for Q4 2022, down 91% quarter-over-quarter.
- 3 funds opened new Intelligent Bio Solutions positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest Intelligent Bio Solutions buyer in Q4 2022 was Citadel Advisors, an estimated $14.4K added.
- The largest Intelligent Bio Solutions seller in Q4 2022 was Gotham Asset Management, an estimated $661K sold.
Based on aggregated 13F filings for Q4 2022.